Renal Biomarkers: Technologies and Global Markets

Jan 2023| BIO138B| BCC Publishing
Sample Report

Report Highlights

The global market for renal biomarkers is estimated to increase from $1.2 billion in 2022 to reach $1.7 billion by 2027, at a compound annual growth rate (CAGR) of 7.6% from 2022 through 2027.

Report Includes

  • 41 data tables and 24 additional tables
  • A detailed overview and up-to-date analysis of the global markets for renal biomarkers
  • Analyses of the global market trends, with market revenue data for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Estimation of the actual market size and revenue forecast for renal biomarkers market, and corresponding market share analysis by assay type, application, end user, and region
  • Updated information on market drivers and opportunities for renal biomarkers, key shifts, regulations and industry specific challenges, and other demographic factors that will shape the market demand over the coming years (2022-2027)
  • Identification of the companies best positioned to meet the demand owing to their proprietary technologies, product launches, mergers and acquisitions, and other market strategic advantages
  • Review of recent industry structure for biomarkers, R&D activities, and analysis of the competitive landscape based on recent developments and segmental revenues
  • Patent activity and review of patent grants for biomarkers and related technologies
  • Descriptive company profiles of the market leading players, including BioMerieux, Gentian Diagnostic, Proteomics International, Thermo Fisher Scientific, SphingoTec, and BioPorto

Report Scope

This report incorporates an in-depth analysis of the renal biomarker market, including market estimations and trends through 2021. Major players, competitive intelligence, innovative technologies, market dynamics and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The patent analysis focuses on technological trends in recent years in regions such as the U.S., Europe, and Japan. The report presents a market analysis and estimates the CAGR for renal biomarkers.

The scope of the report extends only to renal biomarker consumables and not devices used to study renal biomarkers. All types of renal biomarkers have been considered in research, clinical trials and for diagnostic purposes.

This report segments the global market by these geographic regions: North America, Europe, Asia-Pacific, and the Rest of the World (RoW) region. For market estimates, data is provided for 2021 as the base year, 2022 and forecast through year-end 2027.

Frequently Asked Questions (FAQs)

The renal biomarker market is projected to grow from $1.1 billion in 2021 to $1.7 in 2027, at a compound annual growth rate (CAGR) of 7.6% during the forecast period.
The key factors driving the growth of renal biomarker market includes , the increasing prevalence of AKI, aging population trend is leading to deterioration of kidney health and incidence of CKD are on a rise.
The renal biomarker market is segmented based on type, technique, end user and region.
Filtered renal biomarkers will dominate the market during the forecasting period.
North America holds the highest share in the market.
Key companies in the market includes Abbot, Bio-rad, Biomerieux, ThermoFischer Scientific and Proteomics International.

Analyst Credentials

BCC Publishing Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2027
Base year market size $1.1 billion
Market size forecast $1.7 billion
Growth rate CAGR of 7.6% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered Segment, Region, Country, Type, End-User, and Technique
Regions covered North America, Europe, Asia-Pacific, Rest of the World (RoW)
Countries covered U.S., Canada, France, Germany, UK, Italy, Spain, China, Australia, and Japan
Key Market Drivers
  • Prevalence of Chronic Kidney Diseases
  • Rising Cases of Acute Kidney Injury
  • Renal Biomarker Applications in Clinical Trials
  • Aging Increases the Prevalence of Kidney Diseases
  • Increasing Awareness of Kidney Diseases
  • Availability of New Biomarkers
Companies studied
ABBOTT LABORATORIES
BECKMAN COULTER INC.
BIOMERIEUX
BIOPORTO A/S
BIO-RAD
ENZO BIOCHEM INC.
GENTIAN DIAGNOSTIC AB
HYTEST LTD.
NEPHROSANT
Nexelis
PROTEOMICS INTERNATIONAL LABORATORIES LTD.
RANDOX LABORATORIES LTD.
ROCHE (F. HOFFMANN-LA ROCHE AG)
SPHINGOTEC
THERMO FISHER SCIENTIFIC

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesPrice Member Price
Full Report: Renal Biomarkers: Technologies and Global Markets93 $5,500 Free
Chapter- 1: Introduction5Free DownloadFree
Chapter- 2: Summary and Highlights2$250Free
Chapter- 3: Market Overview19$1,124Free
Chapter- 4: Impact of COVID-19 Pandemic6$355Free
Chapter- 5: Global Renal Biomarker Market by Type8$473Free
Chapter- 6: Global Market for Renal Biomarkers by Region22$1,301Free
Chapter- 7: Renal Biomarker Market by End User 2$118Free
Chapter- 8: Renal Biomarker Market by Technique 4$237Free
Chapter- 9: Competitive Landscape3$177Free
Chapter- 10: Company Profiles17$1,005Free
Chapter- 11: Patent Review3$177Free
Chapter- 12: Clinical Trial Analysis2$118Free
Published - Jan-2015| Analyst - Cheng-Yuk Lee| Code - BIO138A

Report Highlights

The in vitro diagnostic renal biomarker market was valued at $771 million in 2013 and $812 million in 2014. The market is expected to reach $1.1 billion by 2019, a compound annual growth rate (CAGR) of 7% from 2014 to 2019.

Report Includes

  • A comprehensive analysis of renal biomarkers global markets and technologies.
  • Analyses of global market trends, with data from 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019.
  • Details pertaining to the history and current state of chronic kidney disease (CKD), background information on renal biomarkers, and current industrial technologies used for diagnosis.
  • In-depth analyses of the predominant biomarkers in the market, namely creatinine, and emerging biomarkers like NGAL, KIM-1, L-FABP and many others.
  • Discussion concerning intellectual property, the regulatory requirement, and the competitive landscape of the industry.
  • Comprehensive profiles of major players in the renal biomarkers field.
Renal Biomarkers: Technologies and Global Markets

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS